Publications of Marc D. Ryser    :chronological  alphabetical  combined  bibtex listing:

Papers Published

1. Nguyen, DL; Shelley Hwang, E; Ryser, MD; Grimm, LJ, Imaging Changes and Outcomes of Patients Undergoing Active Monitoring for Ductal Carcinoma In Situ: Seven-Year Follow-up Study., Acad Radiol, vol. 31 no. 7 (July, 2024), pp. 2654-2662 [doi]  [abs]
2. Iyer, M; Mallo, D; Maley, CC; Fortunato, A; Cisneros, L; King, LM; Ryser, MD; Lo, JY; Hall, A; Marks, JR; Hwang, S, Abstract A038: Evaluating DCIS progression: A comparative analysis of CNA predictive power derived from lpWGS and WES data, Cancer Research, vol. 84 no. 3_Supplement_2 (February, 2024), pp. A038-A038, American Association for Cancer Research (AACR) [doi]  [abs]
3. Liu, X; Ren, Y; Ryser, M; Grimm, LJ; Lo, JY, A Residual-Attention Multimodal Fusion Network (ResAMF-Net) for Detection and Classification of Breast Cancer, Progress in Biomedical Optics and Imaging - Proceedings of SPIE, vol. 12927 (January, 2024), ISBN 9781510671584 [doi]  [abs]
4. Schmitz, RSJM; van den Belt-Dusebout, AW; Clements, K; Ren, Y; Cresta, C; Timbres, J; Liu, Y-H; Byng, D; Lynch, T; Menegaz, BA; Collyar, D; Hyslop, T; Thomas, S; Love, JK; Schaapveld, M; Bhattacharjee, P; Ryser, MD; Sawyer, E; Hwang, ES; Thompson, A; Wesseling, J; Lips, EH; Schmidt, MK; Grand Challenge PRECISION consortium, Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study., BMJ, vol. 383 (October, 2023), pp. e076022 [doi]  [abs]
5. Ryser, MD; Greenwald, MA; Sorribes, IC; King, LM; Hall, A; Geradts, J; Weaver, DL; Mallo, D; Holloway, S; Monyak, D; Gumbert, G; Vaez-Ghaemi, S; Wu, E; Murgas, K; Grimm, LJ; Maley, CC; Marks, JR; Shibata, D; Hwang, ES, Growth Dynamics of Ductal Carcinoma in Situ Recapitulate Normal Breast Development., bioRxiv (October, 2023) [doi]  [abs]
6. Lange, J; Zhao, Y; Gogebakan, KC; Olivas-Martinez, A; Ryser, MD; Gard, CC; Etzioni, R, Test sensitivity in a prospective cancer screening program: A critique of a common proxy measure., Stat Methods Med Res, vol. 32 no. 6 (June, 2023), pp. 1053-1063 [doi]  [abs]
7. Byng, D; Thomas, SM; Rushing, CN; Lynch, T; McCarthy, A; Francescatti, AB; Frank, ES; Partridge, AH; Thompson, AM; Retèl, VP; van Harten, WH; Grimm, LJ; Hyslop, T; Hwang, ES; Ryser, MD, Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ., Radiology, vol. 307 no. 1 (April, 2023), pp. e221210 [doi]  [abs]
8. Etzioni, R; Gulati, R; Owens, L; Lange, J; Ryser, MD, Abstract IA018: Opportunity for interception as a driver of benefit in cancer early detection: implications for multi-cancer early detection testing, Cancer Prevention Research, vol. 16 no. 1_Supplement (January, 2023), pp. IA018-IA018, American Association for Cancer Research (AACR) [doi]  [abs]
9. Etzioni, R; Gulati, R; Owens, L; Lange, J; Ryser, MD, Opportunity for interception as a driver of benefit in cancer early detection: implications for multi-cancer early detection testing., CANCER PREVENTION RESEARCH, vol. 16 no. 1 (2023), pp. 6-6
10. Lynch, T; Basila, D; Schnitt, SJ; Marks, JR; Strand, SH; Hyslop, T; Badve, SS; Watson, MA; Le-Petross, HT; Grimm, L; West, RB; Weiss, A; Rapperport, A; King, L; Factor, RE; Ryser, MD; Partridge, AH; Hwang, E-SS; Thompson, AM; Collyar, DE, From the lab to the clinic: Lessons learned from a translational working group., JOURNAL OF CLINICAL ONCOLOGY, vol. 41 no. 16 (2023)
11. Fridman, I; Chan, L; Thomas, J; Fish, LJ; Falkovic, M; Brioux, J; Hunter, N; Ryser, DH; Hwang, ES; Pollak, KI; Weinfurt, KP; Ryser, MD, A web-based personalized decision support tool for patients diagnosed with ductal carcinoma in situ: development, content evaluation, and usability testing., Breast Cancer Res Treat, vol. 192 no. 3 (April, 2022), pp. 517-527 [doi]  [abs]
12. Ryser, MD; Lange, J; Inoue, LYT; O'Meara, ES; Gard, C; Miglioretti, DL; Bulliard, J-L; Brouwer, AF; Hwang, ES; Etzioni, RB, Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort., Ann Intern Med, vol. 175 no. 4 (April, 2022), pp. 471-478 [doi]  [abs]
13. Schapiro, D; Yapp, C; Sokolov, A; Reynolds, SM; Chen, Y-A; Sudar, D; Xie, Y; Muhlich, J; Arias-Camison, R; Arena, S; Taylor, AJ; Nikolov, M; Tyler, M; Lin, J-R; Burlingame, EA; Human Tumor Atlas Network; Chang, YH; Farhi, SL; Thorsson, V; Venkatamohan, N; Drewes, JL; Pe'er, D; Gutman, DA; Herrmann, MD; Gehlenborg, N; Bankhead, P; Roland, JT; Herndon, JM; Snyder, MP; Angelo, M; Nolan, G; Swedlow, JR; Schultz, N; Merrick, DT; Mazzili, SA; Cerami, E; Rodig, SJ; Santagata, S; Sorger, PK, MITI minimum information guidelines for highly multiplexed tissue images., Nat Methods, vol. 19 no. 3 (March, 2022), pp. 262-267 [doi]  [abs]
14. Schmitz, RSJM; van den Belt-Dusebout, SW; Cresta, C; Liu, Y-H; Schaapveld, M; Clements, K; Timbres, J; Byng, DT; Ryser, MD; Ren, Y; Lynch, T; Hyslop, T; Menegaz, B; Collyar, D; Hwang, S; Thompson, A; Sawyer, E; Wesseling, J; Lips, EH; Schmidt, MK, Abstract P1-22-02: Subsequent risk of ipsilateral breast events in a multinational DCIS cohort of 48.619 patients: A meta-analysis within the PRECISION consortium, Cancer Research, vol. 82 no. 4_Supplement (February, 2022), American Association for Cancer Research (AACR) [doi]  [abs]
15. Ryser, MD; Lange, J; Inoue, L; O'Meara, ES; Gard, C; Miglioretti, DL; Bulliard, J-L; Brouwer, AF; Hwang, ES; Etzioni, RB, Abstract GS4-06: Estimation of breast cancer overdiagnosis in a US breast screening cohort, Cancer Research, vol. 82 no. 4_Supplement (February, 2022), American Association for Cancer Research (AACR) [doi]  [abs]
16. Grimm, LJ; Rahbar, H; Abdelmalak, M; Hall, AH; Ryser, MD, Ductal Carcinoma in Situ: State-of-the-Art Review., Radiology, vol. 302 no. 2 (February, 2022), pp. 246-255 [doi]  [abs]
17. Schmitz, RS; van den Belt-Dusebout, AW; Clements, K; Ren, Y; Cresta, C; Timbres, J; Liu, Y-H; Byng, D; Lynch, T; Menegaz, B; Collyar, D; Hyslop, T; Schaapveld, M; Sawyer, E; Hwang, SE; Thompson, A; Ryser, MD; Wesseling, J; Lips, EH; Schmidt, MK, Subsequent invasive breast cancer risk after DCIS treatment in multinational PRECISION consortium cohorts comprising 48,576 patients, CANCER RESEARCH, vol. 82 no. 12 (2022)
18. Murgas, KA; Ma, Y; Shahidi, LK; Mukherjee, S; Allen, AS; Shibata, D; Ryser, MD, A Bayesian hierarchical model to estimate DNA methylation conservation in colorectal tumors., Bioinformatics, vol. 38 no. 1 (December, 2021), pp. 22-29 [doi]  [abs]
19. van Seijen, M; Lips, EH; Fu, L; Giardiello, D; van Duijnhoven, F; de Munck, L; Elshof, LE; Thompson, A; Sawyer, E; Ryser, MD; Hwang, ES; Schmidt, MK; Elkhuizen, PHM; Grand Challenge PRECISION Consortium; Wesseling, J; Schaapveld, M, Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast., Br J Cancer, vol. 125 no. 10 (November, 2021), pp. 1443-1449 [doi]  [abs]
20. Byng, D; Retel, VP; van Harten, W; Rushing, CN; Thomas, SM; Lynch, T; McCarthy, A; Francescatti, AB; Frank, ES; Partridge, AH; Thompson, AM; Grimm, L; Hyslop, T; Hwang, E-SS; Ryser, MD, Disparities in surveillance imaging after breast conserving surgery for primary DCIS., Journal of Clinical Oncology, vol. 39 no. 15_suppl (May, 2021), pp. 6516-6516, American Society of Clinical Oncology (ASCO) [doi]  [abs]
21. Chan, L; Fridman, I; Grant, J; Hwang, ES; Weinfurt, K; Ryser, MD, USING PAIRWISE SIMULATED OUTCOMES TO IMPROVE THE UNDERSTANDING OF THE STATISTICAL DIFFERENCES BETWEEN TWO RISK DISTRIBUTIONS, MEDICAL DECISION MAKING, vol. 41 no. 4 (2021), pp. E284-E286
22. Ryser, MD; Rushing, CN; Thomas, SM; Lynch, T; McCarthy, A; Mohammed, ZA; Francescatti, AB; Frank, ES; Partridge, AH; Thompson, AM; Hyslop, T; Hwang, ES, Ipsilateral invasive cancer risk after diagnosis with ductal carcinoma in situ in patients with and without index surgery: The effects of endocrine therapy and radiation treatment, CANCER RESEARCH, vol. 81 no. 4 (2021)
23. Butt, J; Blot, WJ; Visvanathan, K; Le Marchand, L; Wilkens, LR; Chen, Y; Sesso, HD; Teras, L; Ryser, MD; Hyslop, T; Wassertheil-Smoller, S; Tinker, LF; Potter, JD; Song, M; Berndt, SI; Waterboer, T; Pawlita, M; Epplein, M, Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a U.S. Prospective Cohort Consortium., Cancer Epidemiol Biomarkers Prev, vol. 29 no. 12 (December, 2020), pp. 2729-2734 [doi]  [abs]
24. Brouwer, AF; He, K; Chinn, SB; Mondul, AM; Chapman, CH; Ryser, MD; Banerjee, M; Eisenberg, MC; Meza, R; Taylor, JMG, Time-varying survival effects for squamous cell carcinomas at oropharyngeal and nonoropharyngeal head and neck sites in the United States, 1973-2015., Cancer, vol. 126 no. 23 (December, 2020), pp. 5137-5146 [doi]  [abs]
25. Rodriguez-Homs, LG; Hammill, BG; Ryser, MD; Phillips, HR; Mosca, PJ, Relationship Between HCAHPS Scores and Survey Response Rate Is Linked to Hospital Size., J Patient Exp, vol. 7 no. 6 (December, 2020), pp. 1543-1548 [doi]  [abs]
26. Epplein, M; Le Marchand, L; Cover, TL; Song, M; Blot, WJ; Peek, RM; Teras, LR; Visvanathan, K; Chen, Y; Sesso, HD; Zeleniuch-Jacquotte, A; Berndt, SI; Potter, JD; Ryser, MD; Haiman, CA; Wassertheil-Smoller, S; Tinker, LF; Waterboer, T; Butt, J, Association of Combined Sero-Positivity to Helicobacter pylori and Streptococcus gallolyticus with Risk of Colorectal Cancer., Microorganisms, vol. 8 no. 11 (October, 2020) [doi]  [abs]
27. Shehata, MN; Rahbar, H; Flanagan, MR; Kilgore, MR; Lee, CI; Ryser, MD; Lowry, KP, Risk for Upgrade to Malignancy After Breast Core Needle Biopsy Diagnosis of Lobular Neoplasia: A Systematic Review and Meta-Analysis., J Am Coll Radiol, vol. 17 no. 10 (October, 2020), pp. 1207-1219 [doi]  [abs]
28. Williamson, T; Ryser, MD; Ubel, PA; Abdelgadir, J; Spears, CA; Liu, B; Komisarow, J; Lemmon, ME; Elsamadicy, A; Lad, SP, Withdrawal of Life-supporting Treatment in Severe Traumatic Brain Injury., JAMA Surg, vol. 155 no. 8 (August, 2020), pp. 723-731 [doi]  [abs]
29. Chootipongchaivat, S; van Ravesteyn, NT; Li, X; Huang, H; Weedon-Fekjær, H; Ryser, MD; Weaver, DL; Burnside, ES; Heckman-Stoddard, BM; de Koning, HJ; Lee, SJ, Modeling the natural history of ductal carcinoma in situ based on population data., Breast Cancer Res, vol. 22 no. 1 (May, 2020), pp. 53 [doi]  [abs]
30. Rozenblatt-Rosen, O; Regev, A; Oberdoerffer, P; Nawy, T; Hupalowska, A; Rood, JE; Ashenberg, O; Cerami, E; Coffey, RJ; Demir, E; Ding, L; Esplin, ED; Ford, JM; Goecks, J; Ghosh, S; Gray, JW; Guinney, J; Hanlon, SE; Hughes, SK; Hwang, ES; Iacobuzio-Donahue, CA; Jané-Valbuena, J; Johnson, BE; Lau, KS; Lively, T; Mazzilli, SA; Pe'er, D; Santagata, S; Shalek, AK; Schapiro, D; Snyder, MP; Sorger, PK; Spira, AE; Srivastava, S; Tan, K; West, RB; Williams, EH; Human Tumor Atlas Network, The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution., Cell, vol. 181 no. 2 (April, 2020), pp. 236-249 [doi]  [abs]
31. Ryser, MD; Mallo, D; Hall, A; Hardman, T; King, LM; Tatishchev, S; Sorribes, IC; Maley, CC; Marks, JR; Hwang, ES; Shibata, D, Minimal barriers to invasion during human colorectal tumor growth., Nat Commun, vol. 11 no. 1 (March, 2020), pp. 1280 [doi]  [abs]
32. Ryser, MD; Hwang, ES, Response to Habel and Buist., J Natl Cancer Inst, vol. 112 no. 2 (February, 2020), pp. 216-217 [doi]
33. Fridman, I; Kumaresan, V; Vijendra, P; Seshadri, P; Garland, S; Kim, G; Fagerlin, A; Ubel, PA; Ryser, MD, INFORMATION PROCESSING AND PATIENT DECISION MAKING: A BIG DATA APPROACH TO TREATMENT CHOICE IN PROSTATE CANCER PATIENTS, MEDICAL DECISION MAKING, vol. 40 no. 1 (January, 2020), pp. E183-E184, SAGE PUBLICATIONS INC
34. Ryser, MD; Sorribes, IC; Greenwald, M; Wu, E; Hall, A; Mallo, D; King, LM; Hardman, T; Simpson, L; Maley, CC; Marks, JR; Shibata, D; Hwang, ES, Inferring the evolutionary dynamics of ductal carcinoma in situ through multi-regional sequencing and mathematical modeling., CANCER RESEARCH, vol. 80 no. 21 (2020)
35. Ryser, MD; Hendrix, L; Thomas, SM; Lynch, T; McCarthy, A; Mohammed, Z; Francescatti, AB; Frank, ES; Partridge, AH; Thompson, AM; Hyslop, T; Hwang, E-SS, Ipsilateral invasive cancer risk after diagnosis with ductal carcinoma in situ (DCIS): Comparison of patients with and without index surgery., JOURNAL OF CLINICAL ONCOLOGY, vol. 38 no. 15 (2020)
36. Williamson, T; Ryser, MD; Abdelgadir, J; Lemmon, M; Barks, MC; Zakare, R; Ubel, PA, Surgical decision making in the setting of severe traumatic brain injury: A survey of neurosurgeons., PLoS One, vol. 15 no. 3 (2020), pp. e0228947 [doi]  [abs]
37. Ryser, MD; Weaver, DL; Zhao, F; Worni, M; Grimm, LJ; Gulati, R; Etzioni, R; Hyslop, T; Lee, SJ; Hwang, ES, Cancer Outcomes in DCIS Patients Without Locoregional Treatment., J Natl Cancer Inst, vol. 111 no. 9 (September, 2019), pp. 952-960 [doi]  [abs]
38. Ryser, MD; Hendrix, LH; Worni, M; Liu, Y; Hyslop, T; Hwang, ES, Incidence of Ductal Carcinoma In Situ in the United States, 2000-2014., Cancer Epidemiol Biomarkers Prev, vol. 28 no. 8 (August, 2019), pp. 1316-1323 [doi]  [abs]
39. Grimm, LJ; Miller, MM; Thomas, SM; Liu, Y; Lo, JY; Hwang, ES; Hyslop, T; Ryser, MD, Growth Dynamics of Mammographic Calcifications: Differentiating Ductal Carcinoma in Situ from Benign Breast Disease., Radiology, vol. 292 no. 1 (July, 2019), pp. 77-83 [doi]  [abs]
40. Shen, Y; Dong, W; Gulati, R; Ryser, MD; Etzioni, R, Estimating the frequency of indolent breast cancer in screening trials., Stat Methods Med Res, vol. 28 no. 4 (April, 2019), pp. 1261-1271 [doi]  [abs]
41. Ryser, MD; Gulati, R; Eisenberg, MC; Shen, Y; Hwang, ES; Etzioni, RB, Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials., Am J Epidemiol, vol. 188 no. 1 (January, 2019), pp. 197-205 [doi]  [abs]
42. Ryser, MD; Yu, M; Grady, W; Siegmund, K; Shibata, D, Epigenetic Heterogeneity in Human Colorectal Tumors Reveals Preferential Conservation And Evidence of Immune Surveillance., Sci Rep, vol. 8 no. 1 (November, 2018), pp. 17292 [doi]  [abs]
43. Ryser, MD; Min, B-H; Siegmund, KD; Shibata, D, Spatial mutation patterns as markers of early colorectal tumor cell mobility., Proc Natl Acad Sci U S A, vol. 115 no. 22 (May, 2018), pp. 5774-5779 [doi]  [abs]
44. Grimm, LJ; Ryser, MD; Hyslop, T, Role of Preoperative Variables in Reducing the Rate of Occult Invasive Disease for Women Considering Active Surveillance for Ductal Carcinoma In Situ., JAMA Surg, vol. 153 no. 3 (March, 2018), pp. 290-291 [doi]
45. Ryser, MD; Horton, JK; Hwang, ES, How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS., Ann Surg Oncol, vol. 25 no. 2 (February, 2018), pp. 354-355 [doi]
46. Grimm, LJ; Ryser, MD; Partridge, AH; Thompson, AM; Thomas, JS; Wesseling, J; Hwang, ES, Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials., Annals of surgical oncology, vol. 24 no. 12 (November, 2017), pp. 3534-3540 [doi]  [abs]
47. Cao, Y; Feng, Y; Ryser, MD; Zhu, K; Herschlag, G; Cao, C; Marusak, K; Zauscher, S; You, L, Programmable assembly of pressure sensors using pattern-forming bacteria., Nat Biotechnol, vol. 35 no. 11 (November, 2017), pp. 1087-1093 [doi]  [abs]
48. Ryser, MD; Rositch, A; Gravitt, PE, Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution., J Infect Dis, vol. 216 no. 5 (September, 2017), pp. 604-611 [doi]  [abs]
49. Ryser, MD; Gravitt, PE; Myers, ER, Mechanistic mathematical models: An underused platform for HPV research., Papillomavirus Res, vol. 3 (June, 2017), pp. 46-49 [doi]  [abs]
50. Ryser, MD; Murgas, KA, Bone remodeling as a spatial evolutionary game., J Theor Biol, vol. 418 (April, 2017), pp. 16-26 [doi]  [abs]
51. Storey, K; Ryser, MD; Leder, K; Foo, J, Spatial Measures of Genetic Heterogeneity During Carcinogenesis., Bull Math Biol, vol. 79 no. 2 (February, 2017), pp. 237-276 [doi]  [abs]
52. Ryser, MD; Lee, WT; Ready, NE; Leder, KZ; Foo, J, Quantifying the Dynamics of Field Cancerization in Tobacco-Related Head and Neck Cancer: A Multiscale Modeling Approach., Cancer Res, vol. 76 no. 24 (December, 2016), pp. 7078-7088 [doi]  [abs]
53. Ryser, MD; Worni, M; Turner, EL; Marks, JR; Durrett, R; Hwang, ES, Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis., J Natl Cancer Inst, vol. 108 no. 5 (May, 2016), pp. djv372 [doi]  [abs]
54. Cao, Y; Ryser, MD; Payne, S; Li, B; Rao, CV; You, L, Collective Space-Sensing Coordinates Pattern Scaling in Engineered Bacteria., Cell, vol. 165 no. 3 (April, 2016), pp. 620-630 [doi]  [abs]
55. Worni, M; Akushevich, I; Greenup, R; Sarma, D; Ryser, MD; Myers, ER; Hwang, ES, Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ., J Natl Cancer Inst, vol. 107 no. 12 (December, 2015), pp. djv263 [doi]  [abs]
56. Ryser, MD; McGoff, K; Herzog, DP; Sivakoff, DJ; Myers, ER, Impact of coverage-dependent marginal costs on optimal HPV vaccination strategies., Epidemics, vol. 11 (June, 2015), pp. 32-47, ISSN 1755-4365 [repository], [doi]  [abs]
57. Ryser, MD; Myers, ER; Durrett, R, HPV clearance and the neglected role of stochasticity., PLoS Comput Biol, vol. 11 no. 3 (March, 2015), pp. e1004113 [doi]  [abs]
58. Ryser, MD; Komarova, SV, Mathematical Modeling of Cancer Metastases, in Computational Bioengineering (January, 2015), pp. 211-230, CRC, ISBN 9781466517561 [doi]  [abs]
59. Foo, J; Leder, K; Ryser, MD, Multifocality and recurrence risk: a quantitative model of field cancerization., J Theor Biol, vol. 355 (August, 2014), pp. 170-184 [doi]  [abs]
60. Payne, S; Li, B; Cao, Y; Schaeffer, D; Ryser, MD; You, L, Temporal control of self-organized pattern formation without morphogen gradients in bacteria., Mol Syst Biol, vol. 9 no. 697 (October, 2013), pp. 697 [doi]  [abs]
61. Ryser, MD; Nigam, N; Tupper, PF, On the well-posedness of the stochastic Allen-Cahn equation in two dimensions, Journal of Computational Physics, vol. 231 no. 6 (March, 2012), pp. 2537-2550 [arXiv:1104.0720v4], [1104.0720v4], [doi]  [abs]
62. Hairer, M; Ryser, M; Weber, H, Triviality of the 2D stochastic Allen-Cahn equation, Electronic Journal of Probability, vol. 17 no. none (January, 2012), Institute of Mathematical Statistics [arXiv:1201.3089v1], [1201.3089v1], [doi]  [abs]
63. Ryser, MD; Qu, Y; Komarova, SV, Osteoprotegerin in bone metastases: mathematical solution to the puzzle., PLoS Comput Biol, vol. 8 no. 10 (2012), pp. e1002703 [23093918], [doi]  [abs]
64. Ryser, MD; Komarova, SV; Nigam, N, The cellular dynamics of bone remodeling: A mathematical model, SIAM Journal on Applied Mathematics, vol. 70 no. 6 (April, 2010), pp. 1899-1921 [arXiv:1111.6916v1], [1111.6916v1], [doi]  [abs]
65. Ryser, MD; Nigam, N; Komarova, SV, Mathematical modeling of spatio-temporal dynamics of a single bone multicellular unit., J Bone Miner Res, vol. 24 no. 5 (May, 2009), pp. 860-870 [19063683], [doi]  [abs]
66. Lehning, M; Loewe, H; Ryser, MD; Raderschall, N, Inhomogeneous precipitation distribution and snow transport in steep terrain, Water Resour. Res. (2008) [2007WR006545.shtml]
67. Buenzli, PR; Martin, PA; Ryser, MD, Thermal quantum electrodynamics of nonrelativistic charged fluids., Phys Rev E Stat Nonlin Soft Matter Phys, vol. 75 no. 4 Pt 1 (April, 2007), pp. 041125, ISSN 1539-3755 [arXiv:quant-ph/0701192v2], [17500883], [doi]  [abs]